Cargando…
Stem cell factor produced by tumor cells expands myeloid-derived suppressor cells in mice
Immunotherapy is a novel treatment approach for cancers; however, its therapeutic effects are impeded by myeloid-derived suppressor cells (MDSCs). This study aimed to determine how MDSCs are expanded in cancer hosts. MDSCs were positive for Gr-1 and CD11b. Hepa1-6 hepatoma cells, EL4 lymphoma cells,...
Autores principales: | Lee, Wei-Chen, Hsu, Pao-Yueh, Hsu, Hsiu-Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7347545/ https://www.ncbi.nlm.nih.gov/pubmed/32647215 http://dx.doi.org/10.1038/s41598-020-68061-8 |
Ejemplares similares
-
Myeloid - derived suppressor cells in Type 1 diabetes are an expanded population exhibiting diverse T-cell suppressor mechanisms
por: Grohová, Anna, et al.
Publicado: (2020) -
Myeloid-Derived Suppressor Cells in Solid Tumors
por: Ma, Tianmiao, et al.
Publicado: (2022) -
Myeloid-Derived Suppressor Cells and Mesenchymal Stem/Stromal Cells in Myeloid Malignancies
por: Kapor, Suncica, et al.
Publicado: (2021) -
Myeloid-Derived Suppressor Cells: The Expanding World of Helminth Modulation of the Immune System
por: Stevenson, Mary M., et al.
Publicado: (2022) -
Surgery-induced monocytic myeloid-derived suppressor cells expand regulatory T cells in lung cancer
por: Wang, Jun, et al.
Publicado: (2017)